A
Attilio Guarini
Researcher at University of Bari
Publications - 154
Citations - 3071
Attilio Guarini is an academic researcher from University of Bari. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 22, co-authored 114 publications receiving 2249 citations.
Papers
More filters
Journal ArticleDOI
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.
Andrés J.M. Ferreri,Michele Reni,Marco Foppoli,Maurizio Martelli,Gerasimus A. Pangalis,Maurizio Frezzato,Maria Giuseppina Cabras,Alberto Fabbri,Gaetano Corazzelli,Fiorella Ilariucci,Giuseppe Rossi,Riccardo Soffietti,Caterina Stelitano,Daniele Vallisa,Francesco Zaja,Lucia Zoppegno,Gian Marco Aondio,Giuseppe Avvisati,Monica Balzarotti,Alba A. Brandes,José Luis Crespo Fajardo,Henry L. Gomez,Attilio Guarini,Graziella Pinotti,Luigi Rigacci,Catrina Uhlmann,Piero Picozzi,Paolo Vezzulli,Maurilio Ponzoni,Emanuele Zucca,Federico Caligaris-Cappio,Franco Cavalli +31 more
TL;DR: In patients aged 75 years and younger with primary CNS lymphoma, the addition of high-dose cytarabine to high- dose methotrexate provides improved outcome with acceptable toxicity compared with high- doses of metotrexate alone.
Journal ArticleDOI
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
Francesco Passamonti,Chiara Cattaneo,Luca Arcaini,Riccardo Bruna,Michele Cavo,Francesco Merli,Emanuele Angelucci,Mauro Krampera,Roberto Cairoli,Matteo G. Della Porta,Nicola Stefano Fracchiolla,Marco Ladetto,Carlo Gambacorti Passerini,Marco Salvini,Monia Marchetti,Roberto M. Lemoli,Alfredo Molteni,Alessandro Busca,Antonio Cuneo,Alessandra Romano,Nicola Giuliani,Sara Galimberti,Alessandro Corso,Alessandro Morotti,Brunangelo Falini,Atto Billio,Filippo Gherlinzoni,Giuseppe Visani,Maria Chiara Tisi,Agostino Tafuri,Patrizia Tosi,Francesco Lanza,Massimo Massaia,Mauro Turrini,Felicetto Ferrara,Carmela Gurrieri,Daniele Vallisa,Maurizio Martelli,Enrico Derenzini,Attilio Guarini,Annarita Conconi,Annarosa Cuccaro,Laura Cudillo,Domenico Russo,Fabrizio Ciambelli,Anna Maria Scattolin,Mario Luppi,Carmine Selleri,Elettra Ortu La Barbera,Celestino Ferrandina,Nicola Di Renzo,Attilio Olivieri,Monica Bocchia,Massimo Gentile,Francesco Marchesi,Pellegrino Musto,Augusto B. Federici,Anna Candoni,Adriano Venditti,Carmen Fava,Antonio Pinto,Piero Galieni,Luigi Rigacci,Daniele Armiento,Fabrizio Pane,Margherita Oberti,Patrizia Zappasodi,Carlo Visco,Matteo Franchi,Paolo Grossi,Lorenza Bertù,Giovanni Corrao,Livio Pagano,Paolo Corradini +73 more
TL;DR: This study adds to the evidence that patients with haematological malignancies have worse outcomes and the general Italian population with COVID-19 has high mortality, by calculating standardised mortality ratios between observed death in the study cohort and expected death by applying stratum-specific mortality rates.
Journal ArticleDOI
Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis
Erika M. Palmieri,Alessio Menga,Rosa Martín-Pérez,Annamaria Quinto,Carla Riera-Domingo,Giacoma De Tullio,Douglas C. Hooper,Wouter H. Lamers,Wouter H. Lamers,Bart Ghesquière,Daniel W. McVicar,Attilio Guarini,Massimiliano Mazzone,Alessandra Castegna +13 more
TL;DR: It is reported that pharmacologic inhibition of GS skews M2-polarized macrophages toward the M1-like phenotype, characterized by reduced intracellular glutamine and increased succinate with enhanced glucose flux through glycolysis, which could be partly related to HIF1α activation.
Journal ArticleDOI
Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation
Vincenzo Pavone,Francesco Gaudio,Giuseppe Console,Umberto Vitolo,Pasquale Iacopino,Attilio Guarini,Vincenzo Liso,Tommasina Perrone,Arcangelo Liso +8 more
TL;DR: It is concluded that in NHL patients, poor mobilization status is predictive of survival and refractory disease status and chemotherapeutic load before mobilization played a negative role and were associated with poor mobilization.
Journal ArticleDOI
Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma
Roberto Ria,Katia Todoerti,Simona Berardi,Addolorata Coluccia,Annunziata De Luisi,Michela Mattioli,Domenica Ronchetti,Fortunato Morabito,Attilio Guarini,Maria Teresa Petrucci,Franco Dammacco,Domenico Ribatti,Antonino Neri,Angelo Vacca +13 more
TL;DR: The distinct endothelial cell gene expression profiles and vascular phenotypes detected in this study may influence remodeling of the bone marrow microenvironment in patients with active multiple myeloma.